Evolution of Osteosarcoma care In institution with development of Low cost easy to administer, outpatient based “OGS-12” protocol with internationally comparable results and adopted in prestigious international guidelines (ESMO, ARIA)
- Bajpai Jal. Osteosarcoma journey over two decades in India: Small steps, big changes; Pediatr Blood Cancer. 2019; e27877. https://doi.org/10.1002/pbc.27877
- Bajpai Jal. Outcomes in Treatment-Naïve Patients with Metastatic Extremity Osteosarcoma Treated with OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center; Journal of Global Oncology.2018. (4):1-10.